Hypomethylating agents are a class of drugs that inhibit DNA methylation. These agents are primarily used in the treatment of certain types of cancers, including myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). By reducing the methylation of DNA, they promote the activation of tumor suppressor genes, which can inhibit the growth of cancer cells.